Deborah Barlow

755 total citations
26 papers, 546 citations indexed

About

Deborah Barlow is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Deborah Barlow has authored 26 papers receiving a total of 546 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Cellular and Molecular Neuroscience and 6 papers in Physiology. Recurrent topics in Deborah Barlow's work include Bone Metabolism and Diseases (5 papers), Receptor Mechanisms and Signaling (4 papers) and Neurotransmitter Receptor Influence on Behavior (4 papers). Deborah Barlow is often cited by papers focused on Bone Metabolism and Diseases (5 papers), Receptor Mechanisms and Signaling (4 papers) and Neurotransmitter Receptor Influence on Behavior (4 papers). Deborah Barlow collaborates with scholars based in United States, Italy and United Kingdom. Deborah Barlow's co-authors include Karen L. Houseknecht, Tobin J. Dickerson, Kevin M. Creehan, Michael A. Taffe, M. Jerry Wright, Shawn M. Aarde, Sophia A. Vandewater, Meghan May, Katherine J. Motyl and Calvin Vary and has published in prestigious journals such as PLoS ONE, Scientific Reports and Endocrinology.

In The Last Decade

Deborah Barlow

23 papers receiving 535 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Deborah Barlow United States 14 231 184 176 132 61 26 546
Fumio Ichinose Japan 7 191 0.8× 190 1.0× 100 0.6× 130 1.0× 24 0.4× 14 393
Samuel A. Roiko United States 13 153 0.7× 115 0.6× 198 1.1× 33 0.3× 10 0.2× 15 466
Hideki Komatsu Japan 17 55 0.2× 27 0.1× 275 1.6× 68 0.5× 84 1.4× 60 893
Jennifer Kuo United States 8 106 0.5× 28 0.2× 149 0.8× 40 0.3× 12 0.2× 19 612
François Chavant France 10 102 0.4× 44 0.2× 78 0.4× 13 0.1× 28 0.5× 13 309
Marta Vachová Czechia 8 95 0.4× 38 0.2× 37 0.2× 36 0.3× 149 2.4× 21 627
S. Balabanova Germany 10 53 0.2× 107 0.6× 64 0.4× 27 0.2× 12 0.2× 41 358
Elena Kornyeyeva United States 5 67 0.3× 34 0.2× 52 0.3× 37 0.3× 25 0.4× 5 459
José A. Pino Chile 13 87 0.4× 12 0.1× 182 1.0× 15 0.1× 54 0.9× 21 456
Paul Maertens United States 13 96 0.4× 12 0.1× 217 1.2× 17 0.1× 105 1.7× 36 773

Countries citing papers authored by Deborah Barlow

Since Specialization
Citations

This map shows the geographic impact of Deborah Barlow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah Barlow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah Barlow more than expected).

Fields of papers citing papers by Deborah Barlow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah Barlow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah Barlow. The network helps show where Deborah Barlow may publish in the future.

Co-authorship network of co-authors of Deborah Barlow

This figure shows the co-authorship network connecting the top 25 collaborators of Deborah Barlow. A scholar is included among the top collaborators of Deborah Barlow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah Barlow. Deborah Barlow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barlow, Deborah, et al.. (2025). Optimization of an Hsp90β-selective inhibitor via exploration of the Hsp90 N-terminal ATP-binding pocket. European Journal of Medicinal Chemistry. 297. 117925–117925. 2 indexed citations
2.
Campbell, Christopher S., Sanket J. Mishra, Deborah Barlow, et al.. (2024). Inhibiting spinal cord-specific hsp90 isoforms reveals a novel strategy to improve the therapeutic index of opioid treatment. Scientific Reports. 14(1). 14715–14715. 4 indexed citations
3.
4.
5.
Barlow, Deborah, et al.. (2021). Housing Temperature Influences Atypical Antipsychotic Drug‐Induced Bone Loss in Female C57BL / 6J Mice. JBMR Plus. 5(10). e10541–e10541. 8 indexed citations
6.
Abi‐Raad, Rita, Manju L. Prasad, Syed M. Gilani, et al.. (2020). Quantitative assessment of p16 expression in FNA specimens from head and neck squamous cell carcinoma and correlation with HPV status. Cancer Cytopathology. 129(5). 394–404. 13 indexed citations
7.
May, Meghan, et al.. (2020). Antipsychotic-induced immune dysfunction: A consideration for COVID-19 risk. Brain Behavior & Immunity - Health. 6. 100097–100097. 28 indexed citations
8.
Carvalho, Adriana Lelis, Daniel J. Brooks, Deborah Barlow, et al.. (2020). Sustained Morphine Delivery Suppresses Bone Formation and Alters Metabolic and Circulating miRNA Profiles in Male C57BL/6J Mice. Journal of Bone and Mineral Research. 37(11). 2226–2243. 4 indexed citations
9.
10.
May, Meghan, et al.. (2019). The antipsychotic medication, risperidone, causes global immunosuppression in healthy mice. PLoS ONE. 14(6). e0218937–e0218937. 38 indexed citations
11.
Guntur, Anyonya R., Phuong Le, Deborah Barlow, et al.. (2019). Exploring mechanisms of increased cardiovascular disease risk with antipsychotic medications: Risperidone alters the cardiac proteomic signature in mice. Pharmacological Research. 152. 104589–104589. 23 indexed citations
12.
Stefanucci, Azzurra, Marilisa Pia Dimmito, Giorgia Macedonio, et al.. (2019). Potent, Efficacious, and Stable Cyclic Opioid Peptides with Long Lasting Antinociceptive Effect after Peripheral Administration. Journal of Medicinal Chemistry. 63(5). 2673–2687. 17 indexed citations
13.
14.
Motyl, Katherine J., Deborah Barlow, Phuong Le, et al.. (2017). A novel role for dopamine signaling in the pathogenesis of bone loss from the atypical antipsychotic drug risperidone in female mice. Bone. 103. 168–176. 38 indexed citations
15.
Motyl, Katherine J., Victoria DeMambro, Deborah Barlow, et al.. (2015). Propranolol Attenuates Risperidone-Induced Trabecular Bone Loss in Female Mice. Endocrinology. 156(7). 2374–2383. 28 indexed citations
16.
Aarde, Shawn M., Deborah Barlow, M. Jerry Wright, et al.. (2013). Mephedrone (4-methylmethcathinone) supports intravenous self-administration in Sprague-Dawley and Wistar rats. Addiction Biology. 18(5). 786–799. 82 indexed citations
17.
Miller, Michelle L., Kevin M. Creehan, Deborah Barlow, et al.. (2012). Changes in ambient temperature differentially alter the thermoregulatory, cardiac and locomotor stimulant effects of 4-methylmethcathinone (mephedrone). Drug and Alcohol Dependence. 127(1-3). 248–253. 48 indexed citations
18.
Wright, M. Jerry, Shawn M. Aarde, Deborah Barlow, et al.. (2012). Effect of Ambient Temperature on the Thermoregulatory and Locomotor Stimulant Effects of 4-Methylmethcathinone in Wistar and Sprague-Dawley Rats. PLoS ONE. 7(8). e44652–e44652. 80 indexed citations
19.
Drexler, Dieter M., Deborah Barlow, Paul Falk, et al.. (2006). Development of an on-line automated sample clean-up method and liquid chromatography–tandem mass spectrometry analysis: application in an in vitro proteolytic assay. Analytical and Bioanalytical Chemistry. 384(5). 1145–1154. 8 indexed citations
20.
Hart, David T., et al.. (1989). Antiparasitic drug design. Parasitology Today. 5(4). 117–120. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fumio Ichinose Breakdown of academic impact, for papers by Samuel A. Roiko Breakdown of academic impact, for papers by Hideki Komatsu Breakdown of academic impact, for papers by Jennifer Kuo Breakdown of academic impact, for papers by François Chavant Breakdown of academic impact, for papers by Marta Vachová Breakdown of academic impact, for papers by S. Balabanova Breakdown of academic impact, for papers by Elena Kornyeyeva Breakdown of academic impact, for papers by José A. Pino Breakdown of academic impact, for papers by Paul Maertens
Rankless by CCL
2026